Therapeutic Drug Class · 1 Standardized Monograph

Antifolate disease-modifying antirheumatic drug

Antifolate antimetabolite disease-modifying antirheumatic drugs (DMARDs) competitively inhibit dihydrofolate reductase and increase extracellular adenosine release, exerting potent anti-inflammatory and immunomodulatory effects in rheumatoid arthritis and severe psoriasis.

  • ✓ Reviewed by Dr. Lisa M., PharmD · Pharmacotherapy Specialist
  • ✓ CDSCO & FDA Clinical Guidance Aligned
  • ✓ 100% Free Public Reference
Showing 1 medicine monograph in class: “Antifolate disease-modifying antirheumatic drug”
Tablet Rx Only

Methotrexate

Brands: Folitrax, Trexall, Mexate, Imutrex (India)

Anchor disease-modifying antirheumatic drug taken strictly ONCE PER WEEK with folic acid to control rheumatoid arthritis…

🧮

Explore Clinical Health & Dosage Calculators

Use our evidence-based clinical calculators to compute BMI, protein targets, daily calorie balance, and hydration requirements.

Open Health Calculators →
🛡️
Medical & Pharmacological Disclaimer: Content published across the 4mg.in therapeutic drug class directory is intended strictly for educational and public reference. It does not constitute medical advice, diagnosis, or personalized treatment guidance. Always consult a registered physician or licensed pharmacist regarding prescription medication and dosage regimens. Read our Editorial & Fact-Checking Policy.